Palvella Therapeutics, Inc. (PVLA) Net income 2016–2025
Palvella Therapeutics, Inc. (PVLA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$41.7MFY2025 · since FY2016: -$22.8M → -$41.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.7M | -139.3% |
| FY2024 | -$17.4M | -193.3% |
| FY2023 | $18.7M | +156.2% |
| FY2022 | -$33.3M | +27.2% |
| FY2021 | -$45.7M | -22.9% |
| FY2020 | -$37.2M | -46.2% |
| FY2019 | -$25.5M | +4.8% |
| FY2018 | -$26.8M | -51.6% |
| FY2017 | -$17.6M | +22.6% |
| FY2016 | -$22.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PVLA financial trends
PVLA RevenuePVLA Net marginPVLA Gross profitPVLA Gross marginPVLA Operating incomePVLA Operating marginPVLA Operating cash flowPVLA Free cash flowPVLA Capital expendituresPVLA Return on equityPVLA Stock buybacksPVLA Dividends paidPVLA Total assetsPVLA Total liabilitiesPVLA Shareholders’ equityPVLA overview →